The American Physiological Society Press Release

press release logo

APS Contact: APS Communications Office


Phone: 301.634.7209

Twitter: @APSPhysiology

Young and Female: A Good Combination for Kidney Health?

Study finds less extensive damage in young female mice from chemotherapy-induced kidney injury

Bethesda, Md. (September 5, 2017)—Young females may have the greatest level of protection against acute kidney injury (AKI) caused by the chemotherapy drug Cisplatin, commonly used to treat lung, ovarian, bladder and stomach cancer. Nearly a third of all people who are treated with Cisplatin develop AKI. The study—the first to investigate  combined sex and age differences in the response to kidney injury—is published ahead of print in the American Journal of Physiology—Renal Physiology  and was chosen as an APSselect article for September.

Previous research has found that higher expression of an enzyme that breaks down iron in the blood protects both sexes from kidney injury by aiding a function called autophagy.  Autophagy is a self-digestion process that removes damaged cells and promotes the creation of new cells that help repair the kidneys’ duct system. However, autophagic activity naturally slows during the aging process, which may prevent the kidneys from repairing themselves effectively.

Researchers from the University of Alabama at Birmingham, and the Veterans Affairs Medical Center studied four groups of Cisplatin-exposed mice: Young females, old females, young males and old males.  The young male and young female groups both had high amounts of a protein that acts as a marker for autophagy when compared with the old groups. The young males measured somewhat higher protein levels than the young females. Overall, however, the young female group had less kidney damage and inflammation than the old female group and both male groups. This finding suggests that “young females may utilize autophagy more efficiently than other sex/age groups to repair the tubular damage leading to a more robust response to AKI and preservation of renal function,” the research team wrote.

The article, “Unique sex- and age-dependent effects in protective pathways in acute kidney injury,” is published ahead of print in the American Journal of Physiology—Renal Physiology. It is highlighted as one of this month’s “best of the best” as part of the American Physiological Society’s APSselect program. Read all of this month’s selected research articles.

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or 301-634-7209. Find more research highlights in the APS Press Room.

Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.



Not the Weaker Sex: Estrogen Protects Women Against the Flu, Study Finds

Released January 12, 2016 - A new study published in American Journal of Physiology—Lung Cellular and Molecular Physiology finds that the female sex hormone estrogen has anti-viral effects against the influenza A virus, commonly known as the flu. The study supports why the flu may hit men harder than women.

Nobel Laureate, Esteemed Researchers Participate in APS President’s Symposium

Released April 18, 2017 - APS President Jane Reckelhoff, PhD, of the University of Mississippi Medical Center, has developed an engaging President’s Symposium Series to be presented during the 2017 Experimental Biology meeting in Chicago. Three symposia will focus on the theme “Research Advances in Sex/Gender and Developmental Programming of Chronic Diseases.”

New Insight May Lead to Better Detection, Treatment of Common Autoimmune Disease

Released May 3, 2016 - Sjögren's syndrome affects an estimated four million people in the U.S., but diagnosis is often delayed because its symptoms are similar to other conditions. A new study in the American Journal of Physiology—Cell Physiology describes a protein with the potential to be an earlier and more precise indicator of the disease.

Study May Explain Why Stroke Risk in Women Changes after Menopause

Released January 19, 2016 - Overactive microglia—the brain’s immune cells—may worsen the damage from brain injury after stroke or head impact. A new study in American Journal of Physiology—Endocrinology and Metabolism reports that a compound produced from estrogen called 2-methoxyestradiol calms overactive microglia. The findings offer an explanation for why stroke risk in women changes after menopause and point to potential treatments for treating brain injuries in men and women.